Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 4/20 | 0.42 |
| ▸ | PTGDR2 | Q9Y5Y4 | 5/20 | 0.40 |
| ▸ | EDNRB | P24530 | 3/20 | 0.37 |
| ▸ | EDNRA | P25101 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | ADAMTS5 | Q9UNA0 | 2/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.36 |
| ▸ | MMP12 | P39900 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9542846 | 0.85 | PTGDR2 (0.43) | SCN9APTGDR2ALDH1A1ADAMTS5OPRL1 | |
| SCHEMBL9571243 | 0.83 | PTGDR2 (0.42) | SCN9APTGDR2EDNRBEDNRAALDH1A1 | |
| SCHEMBL9571197 | 0.82 | PTGDR2 (0.43) | SCN9APTGDR2ALDH1A1OPRL1KDM4E | |
| SCHEMBL9144120 | 0.81 | PTGDR2 (0.46) | SCN9APTGDR2ALDH1A1OPRL1KDM4E | |
| SCHEMBL9571203 | 0.80 | PTGDR2 (0.46) | SCN9APTGDR2EDNRBEDNRAALDH1A1 | |
| SCHEMBL9541552 | 0.76 | PTGDR2 (0.49) | SCN9APTGDR2ALDH1A1OPRL1KDM4E | |
| SCHEMBL9571205 | 0.75 | PTGDR2 (0.38) | SCN9APTGDR2EDNRBEDNRAALDH1A1 | |
| SCHEMBL9541586 | 0.75 | PTGDR2 (0.45) | SCN9APTGDR2EDNRBEDNRAOPRL1 | |
| SCHEMBL9542788 | 0.74 | PTGDR2 (0.47) | SCN9APTGDR2EDNRBEDNRAALDH1A1 | |
| SCHEMBL9539775 | 0.74 | PTGDR2 (0.44) | SCN9APTGDR2ALDH1A1OPRL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5457201-A | Chiral resolution process | MERCK & CO., INC. (US) | 1995-10-10 | — | — | US | disclosed |
| EP-0569083-A1 | New quinazolines as inhibitors of HIV reverse transcriptase | MERCK & CO. INC. (US) | 1993-11-10 | — | — | EP | disclosed |